nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP2E1—Fingolimod—multiple sclerosis	0.219	0.381	CbGbCtD
Dexmedetomidine—CYP2D6—Fingolimod—multiple sclerosis	0.104	0.182	CbGbCtD
Dexmedetomidine—CYP2E1—Mitoxantrone—multiple sclerosis	0.103	0.179	CbGbCtD
Dexmedetomidine—CYP1A1—Dexamethasone—multiple sclerosis	0.069	0.12	CbGbCtD
Dexmedetomidine—CYP2E1—Dexamethasone—multiple sclerosis	0.0533	0.093	CbGbCtD
Dexmedetomidine—CYP2D6—Dexamethasone—multiple sclerosis	0.0254	0.0443	CbGbCtD
Dexmedetomidine—SLC6A2—nerve—multiple sclerosis	0.00103	0.0998	CbGeAlD
Dexmedetomidine—ADRA2A—peripheral nervous system—multiple sclerosis	0.000938	0.0905	CbGeAlD
Dexmedetomidine—Sweating increased—Betamethasone—multiple sclerosis	0.000601	0.00189	CcSEcCtD
Dexmedetomidine—Sweating increased—Dexamethasone—multiple sclerosis	0.000601	0.00189	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000598	0.00188	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000596	0.00187	CcSEcCtD
Dexmedetomidine—Haemoglobin—Prednisolone—multiple sclerosis	0.000595	0.00187	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000594	0.00187	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000594	0.00187	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000593	0.00186	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000593	0.00186	CcSEcCtD
Dexmedetomidine—Hypotension—Azathioprine—multiple sclerosis	0.000592	0.00186	CcSEcCtD
Dexmedetomidine—Haemorrhage—Prednisolone—multiple sclerosis	0.000592	0.00186	CcSEcCtD
Dexmedetomidine—Cardiac arrest—Prednisone—multiple sclerosis	0.000591	0.00186	CcSEcCtD
Dexmedetomidine—Anaemia—Mitoxantrone—multiple sclerosis	0.00058	0.00182	CcSEcCtD
Dexmedetomidine—Visual impairment—Prednisolone—multiple sclerosis	0.00057	0.00179	CcSEcCtD
Dexmedetomidine—Hypokalaemia—Prednisone—multiple sclerosis	0.000566	0.00178	CcSEcCtD
Dexmedetomidine—Renal failure acute—Methotrexate—multiple sclerosis	0.000563	0.00177	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000556	0.00175	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000556	0.00175	CcSEcCtD
Dexmedetomidine—Bradycardia—Triamcinolone—multiple sclerosis	0.000554	0.00174	CcSEcCtD
Dexmedetomidine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000553	0.00174	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000548	0.00172	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000547	0.00172	CcSEcCtD
Dexmedetomidine—Haemoglobin—Triamcinolone—multiple sclerosis	0.000547	0.00172	CcSEcCtD
Dexmedetomidine—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000546	0.00171	CcSEcCtD
Dexmedetomidine—Haemorrhage—Triamcinolone—multiple sclerosis	0.000544	0.00171	CcSEcCtD
Dexmedetomidine—Convulsion—Mitoxantrone—multiple sclerosis	0.000544	0.00171	CcSEcCtD
Dexmedetomidine—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000543	0.0017	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000542	0.0017	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000542	0.0017	CcSEcCtD
Dexmedetomidine—Hypertension—Mitoxantrone—multiple sclerosis	0.000542	0.0017	CcSEcCtD
Dexmedetomidine—Abdominal distension—Prednisone—multiple sclerosis	0.000541	0.0017	CcSEcCtD
Dexmedetomidine—Hallucination—Methylprednisolone—multiple sclerosis	0.00054	0.0017	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Betamethasone—multiple sclerosis	0.000539	0.00169	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000539	0.00169	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000539	0.00169	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000539	0.00169	CcSEcCtD
Dexmedetomidine—Diarrhoea—Cladribine—multiple sclerosis	0.000533	0.00167	CcSEcCtD
Dexmedetomidine—Anxiety—Mitoxantrone—multiple sclerosis	0.000533	0.00167	CcSEcCtD
Dexmedetomidine—Arrhythmia—Prednisolone—multiple sclerosis	0.000529	0.00166	CcSEcCtD
Dexmedetomidine—Sweating increased—Prednisone—multiple sclerosis	0.000523	0.00164	CcSEcCtD
Dexmedetomidine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000523	0.00164	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000522	0.00164	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000518	0.00163	CcSEcCtD
Dexmedetomidine—Confusional state—Mitoxantrone—multiple sclerosis	0.000517	0.00162	CcSEcCtD
Dexmedetomidine—Dizziness—Cladribine—multiple sclerosis	0.000516	0.00162	CcSEcCtD
Dexmedetomidine—Infection—Mitoxantrone—multiple sclerosis	0.000509	0.0016	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000504	0.00158	CcSEcCtD
Dexmedetomidine—Bradycardia—Betamethasone—multiple sclerosis	0.000503	0.00158	CcSEcCtD
Dexmedetomidine—Bradycardia—Dexamethasone—multiple sclerosis	0.000503	0.00158	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000502	0.00158	CcSEcCtD
Dexmedetomidine—Abdominal pain—Azathioprine—multiple sclerosis	0.000501	0.00157	CcSEcCtD
Dexmedetomidine—Body temperature increased—Azathioprine—multiple sclerosis	0.000501	0.00157	CcSEcCtD
Dexmedetomidine—Tachycardia—Mitoxantrone—multiple sclerosis	0.0005	0.00157	CcSEcCtD
Dexmedetomidine—Haemoglobin—Dexamethasone—multiple sclerosis	0.000496	0.00156	CcSEcCtD
Dexmedetomidine—Haemoglobin—Betamethasone—multiple sclerosis	0.000496	0.00156	CcSEcCtD
Dexmedetomidine—Vomiting—Cladribine—multiple sclerosis	0.000496	0.00156	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000495	0.00156	CcSEcCtD
Dexmedetomidine—Haemorrhage—Betamethasone—multiple sclerosis	0.000494	0.00155	CcSEcCtD
Dexmedetomidine—Haemorrhage—Dexamethasone—multiple sclerosis	0.000494	0.00155	CcSEcCtD
Dexmedetomidine—Angiopathy—Methylprednisolone—multiple sclerosis	0.000493	0.00155	CcSEcCtD
Dexmedetomidine—Rash—Cladribine—multiple sclerosis	0.000492	0.00154	CcSEcCtD
Dexmedetomidine—Hallucination—Betamethasone—multiple sclerosis	0.000491	0.00154	CcSEcCtD
Dexmedetomidine—Hallucination—Dexamethasone—multiple sclerosis	0.000491	0.00154	CcSEcCtD
Dexmedetomidine—Dermatitis—Cladribine—multiple sclerosis	0.000491	0.00154	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000489	0.00154	CcSEcCtD
Dexmedetomidine—Headache—Cladribine—multiple sclerosis	0.000488	0.00153	CcSEcCtD
Dexmedetomidine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000486	0.00153	CcSEcCtD
Dexmedetomidine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000485	0.00152	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Prednisone—multiple sclerosis	0.000485	0.00152	CcSEcCtD
Dexmedetomidine—Hypotension—Mitoxantrone—multiple sclerosis	0.000479	0.0015	CcSEcCtD
Dexmedetomidine—Visual impairment—Betamethasone—multiple sclerosis	0.000476	0.00149	CcSEcCtD
Dexmedetomidine—Visual impairment—Dexamethasone—multiple sclerosis	0.000476	0.00149	CcSEcCtD
Dexmedetomidine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000476	0.00149	CcSEcCtD
Dexmedetomidine—Malnutrition—Methylprednisolone—multiple sclerosis	0.000473	0.00148	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000472	0.00148	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Prednisone—multiple sclerosis	0.00047	0.00147	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00047	0.00147	CcSEcCtD
Dexmedetomidine—Nausea—Cladribine—multiple sclerosis	0.000463	0.00145	CcSEcCtD
Dexmedetomidine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000457	0.00143	CcSEcCtD
Dexmedetomidine—Somnolence—Mitoxantrone—multiple sclerosis	0.000456	0.00143	CcSEcCtD
Dexmedetomidine—Angiopathy—Betamethasone—multiple sclerosis	0.000448	0.00141	CcSEcCtD
Dexmedetomidine—Angiopathy—Dexamethasone—multiple sclerosis	0.000448	0.00141	CcSEcCtD
Dexmedetomidine—Convulsion—Prednisolone—multiple sclerosis	0.000446	0.0014	CcSEcCtD
Dexmedetomidine—Hypertension—Prednisolone—multiple sclerosis	0.000445	0.0014	CcSEcCtD
Dexmedetomidine—SLC6A2—brainstem—multiple sclerosis	0.000444	0.0428	CbGeAlD
Dexmedetomidine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000441	0.00139	CcSEcCtD
Dexmedetomidine—Arrhythmia—Betamethasone—multiple sclerosis	0.000441	0.00139	CcSEcCtD
Dexmedetomidine—Constipation—Mitoxantrone—multiple sclerosis	0.000438	0.00138	CcSEcCtD
Dexmedetomidine—Pain—Mitoxantrone—multiple sclerosis	0.000438	0.00138	CcSEcCtD
Dexmedetomidine—Bradycardia—Prednisone—multiple sclerosis	0.000438	0.00137	CcSEcCtD
Dexmedetomidine—Diarrhoea—Azathioprine—multiple sclerosis	0.000434	0.00136	CcSEcCtD
Dexmedetomidine—Haemoglobin—Prednisone—multiple sclerosis	0.000432	0.00136	CcSEcCtD
Dexmedetomidine—Haemorrhage—Prednisone—multiple sclerosis	0.00043	0.00135	CcSEcCtD
Dexmedetomidine—Hallucination—Prednisone—multiple sclerosis	0.000428	0.00134	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000422	0.00133	CcSEcCtD
Dexmedetomidine—Dizziness—Azathioprine—multiple sclerosis	0.000419	0.00132	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000419	0.00132	CcSEcCtD
Dexmedetomidine—Convulsion—Triamcinolone—multiple sclerosis	0.00041	0.00129	CcSEcCtD
Dexmedetomidine—Tachycardia—Prednisolone—multiple sclerosis	0.00041	0.00129	CcSEcCtD
Dexmedetomidine—Convulsion—Methylprednisolone—multiple sclerosis	0.00041	0.00129	CcSEcCtD
Dexmedetomidine—Hypertension—Triamcinolone—multiple sclerosis	0.000409	0.00128	CcSEcCtD
Dexmedetomidine—Hypertension—Methylprednisolone—multiple sclerosis	0.000408	0.00128	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000406	0.00128	CcSEcCtD
Dexmedetomidine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000405	0.00127	CcSEcCtD
Dexmedetomidine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000405	0.00127	CcSEcCtD
Dexmedetomidine—Vomiting—Azathioprine—multiple sclerosis	0.000403	0.00127	CcSEcCtD
Dexmedetomidine—Pneumonia—Methotrexate—multiple sclerosis	0.000403	0.00126	CcSEcCtD
Dexmedetomidine—Anxiety—Methylprednisolone—multiple sclerosis	0.000401	0.00126	CcSEcCtD
Dexmedetomidine—Rash—Azathioprine—multiple sclerosis	0.0004	0.00125	CcSEcCtD
Dexmedetomidine—Dermatitis—Azathioprine—multiple sclerosis	0.000399	0.00125	CcSEcCtD
Dexmedetomidine—Headache—Azathioprine—multiple sclerosis	0.000397	0.00125	CcSEcCtD
Dexmedetomidine—Dry mouth—Triamcinolone—multiple sclerosis	0.000394	0.00124	CcSEcCtD
Dexmedetomidine—Angiopathy—Prednisone—multiple sclerosis	0.00039	0.00123	CcSEcCtD
Dexmedetomidine—Confusional state—Methylprednisolone—multiple sclerosis	0.000389	0.00122	CcSEcCtD
Dexmedetomidine—ADRA1B—nervous system—multiple sclerosis	0.000385	0.0371	CbGeAlD
Dexmedetomidine—Arrhythmia—Prednisone—multiple sclerosis	0.000384	0.00121	CcSEcCtD
Dexmedetomidine—Infection—Triamcinolone—multiple sclerosis	0.000384	0.00121	CcSEcCtD
Dexmedetomidine—Infection—Methylprednisolone—multiple sclerosis	0.000383	0.0012	CcSEcCtD
Dexmedetomidine—Tachycardia—Triamcinolone—multiple sclerosis	0.000377	0.00118	CcSEcCtD
Dexmedetomidine—Mental disorder—Prednisone—multiple sclerosis	0.000377	0.00118	CcSEcCtD
Dexmedetomidine—ADRA1D—nervous system—multiple sclerosis	0.000377	0.0363	CbGeAlD
Dexmedetomidine—Nausea—Azathioprine—multiple sclerosis	0.000377	0.00118	CcSEcCtD
Dexmedetomidine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000377	0.00118	CcSEcCtD
Dexmedetomidine—Malnutrition—Prednisone—multiple sclerosis	0.000374	0.00118	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000374	0.00117	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000373	0.00117	CcSEcCtD
Dexmedetomidine—Convulsion—Betamethasone—multiple sclerosis	0.000372	0.00117	CcSEcCtD
Dexmedetomidine—Convulsion—Dexamethasone—multiple sclerosis	0.000372	0.00117	CcSEcCtD
Dexmedetomidine—Hypertension—Dexamethasone—multiple sclerosis	0.000371	0.00117	CcSEcCtD
Dexmedetomidine—Hypertension—Betamethasone—multiple sclerosis	0.000371	0.00117	CcSEcCtD
Dexmedetomidine—ADRA1B—central nervous system—multiple sclerosis	0.000371	0.0358	CbGeAlD
Dexmedetomidine—Anxiety—Dexamethasone—multiple sclerosis	0.000365	0.00115	CcSEcCtD
Dexmedetomidine—Anxiety—Betamethasone—multiple sclerosis	0.000365	0.00115	CcSEcCtD
Dexmedetomidine—ADRA1D—central nervous system—multiple sclerosis	0.000363	0.035	CbGeAlD
Dexmedetomidine—Haemoglobin—Methotrexate—multiple sclerosis	0.000361	0.00113	CcSEcCtD
Dexmedetomidine—Hypotension—Methylprednisolone—multiple sclerosis	0.00036	0.00113	CcSEcCtD
Dexmedetomidine—Pain—Prednisolone—multiple sclerosis	0.00036	0.00113	CcSEcCtD
Dexmedetomidine—Haemorrhage—Methotrexate—multiple sclerosis	0.000359	0.00113	CcSEcCtD
Dexmedetomidine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000351	0.0011	CcSEcCtD
Dexmedetomidine—Infection—Dexamethasone—multiple sclerosis	0.000349	0.00109	CcSEcCtD
Dexmedetomidine—Infection—Betamethasone—multiple sclerosis	0.000349	0.00109	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000346	0.00109	CcSEcCtD
Dexmedetomidine—Visual impairment—Methotrexate—multiple sclerosis	0.000346	0.00109	CcSEcCtD
Dexmedetomidine—Anaemia—Prednisone—multiple sclerosis	0.000346	0.00109	CcSEcCtD
Dexmedetomidine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000345	0.00108	CcSEcCtD
Dexmedetomidine—Agitation—Prednisone—multiple sclerosis	0.000344	0.00108	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000343	0.00108	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000343	0.00108	CcSEcCtD
Dexmedetomidine—Tachycardia—Dexamethasone—multiple sclerosis	0.000342	0.00108	CcSEcCtD
Dexmedetomidine—Tachycardia—Betamethasone—multiple sclerosis	0.000342	0.00108	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000339	0.00106	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000339	0.00106	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000334	0.00105	CcSEcCtD
Dexmedetomidine—Pain—Triamcinolone—multiple sclerosis	0.000331	0.00104	CcSEcCtD
Dexmedetomidine—Hypotension—Betamethasone—multiple sclerosis	0.000328	0.00103	CcSEcCtD
Dexmedetomidine—Hypotension—Dexamethasone—multiple sclerosis	0.000328	0.00103	CcSEcCtD
Dexmedetomidine—Angiopathy—Methotrexate—multiple sclerosis	0.000326	0.00102	CcSEcCtD
Dexmedetomidine—Vomiting—Mitoxantrone—multiple sclerosis	0.000326	0.00102	CcSEcCtD
Dexmedetomidine—Convulsion—Prednisone—multiple sclerosis	0.000324	0.00102	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000324	0.00102	CcSEcCtD
Dexmedetomidine—Hypertension—Prednisone—multiple sclerosis	0.000323	0.00101	CcSEcCtD
Dexmedetomidine—Rash—Mitoxantrone—multiple sclerosis	0.000323	0.00101	CcSEcCtD
Dexmedetomidine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000323	0.00101	CcSEcCtD
Dexmedetomidine—Chills—Methotrexate—multiple sclerosis	0.000322	0.00101	CcSEcCtD
Dexmedetomidine—Headache—Mitoxantrone—multiple sclerosis	0.000321	0.00101	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000319	0.001	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000318	0.000998	CcSEcCtD
Dexmedetomidine—Anxiety—Prednisone—multiple sclerosis	0.000318	0.000997	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000315	0.00099	CcSEcCtD
Dexmedetomidine—Mental disorder—Methotrexate—multiple sclerosis	0.000315	0.000989	CcSEcCtD
Dexmedetomidine—Malnutrition—Methotrexate—multiple sclerosis	0.000313	0.000982	CcSEcCtD
Dexmedetomidine—SLC6A2—medulla oblongata—multiple sclerosis	0.00031	0.0299	CbGeAlD
Dexmedetomidine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000306	0.00096	CcSEcCtD
Dexmedetomidine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000305	0.000958	CcSEcCtD
Dexmedetomidine—Nausea—Mitoxantrone—multiple sclerosis	0.000304	0.000956	CcSEcCtD
Dexmedetomidine—Infection—Prednisone—multiple sclerosis	0.000304	0.000953	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000303	0.000951	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000303	0.000951	CcSEcCtD
Dexmedetomidine—Pain—Betamethasone—multiple sclerosis	0.0003	0.000942	CcSEcCtD
Dexmedetomidine—Pain—Dexamethasone—multiple sclerosis	0.0003	0.000942	CcSEcCtD
Dexmedetomidine—Tachycardia—Prednisone—multiple sclerosis	0.000298	0.000936	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000295	0.000927	CcSEcCtD
Dexmedetomidine—ADRA1B—brain—multiple sclerosis	0.000294	0.0284	CbGeAlD
Dexmedetomidine—Anaemia—Methotrexate—multiple sclerosis	0.000289	0.000908	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000289	0.000908	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000289	0.000908	CcSEcCtD
Dexmedetomidine—ADRA1D—brain—multiple sclerosis	0.000288	0.0278	CbGeAlD
Dexmedetomidine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000287	0.000901	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000287	0.000901	CcSEcCtD
Dexmedetomidine—Dizziness—Prednisolone—multiple sclerosis	0.000278	0.000873	CcSEcCtD
Dexmedetomidine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000277	0.000871	CcSEcCtD
Dexmedetomidine—Abdominal pain—Betamethasone—multiple sclerosis	0.000277	0.000871	CcSEcCtD
Dexmedetomidine—Body temperature increased—Betamethasone—multiple sclerosis	0.000277	0.000871	CcSEcCtD
Dexmedetomidine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000277	0.000871	CcSEcCtD
Dexmedetomidine—ADRA2C—medulla oblongata—multiple sclerosis	0.000274	0.0265	CbGeAlD
Dexmedetomidine—Convulsion—Methotrexate—multiple sclerosis	0.000271	0.000851	CcSEcCtD
Dexmedetomidine—Rash—Prednisolone—multiple sclerosis	0.000265	0.000832	CcSEcCtD
Dexmedetomidine—Dermatitis—Prednisolone—multiple sclerosis	0.000265	0.000832	CcSEcCtD
Dexmedetomidine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000264	0.000829	CcSEcCtD
Dexmedetomidine—Headache—Prednisolone—multiple sclerosis	0.000263	0.000827	CcSEcCtD
Dexmedetomidine—Constipation—Prednisone—multiple sclerosis	0.000261	0.00082	CcSEcCtD
Dexmedetomidine—Confusional state—Methotrexate—multiple sclerosis	0.000257	0.000808	CcSEcCtD
Dexmedetomidine—Dizziness—Triamcinolone—multiple sclerosis	0.000256	0.000803	CcSEcCtD
Dexmedetomidine—Dizziness—Methylprednisolone—multiple sclerosis	0.000255	0.000801	CcSEcCtD
Dexmedetomidine—Infection—Methotrexate—multiple sclerosis	0.000254	0.000796	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Prednisone—multiple sclerosis	0.000252	0.00079	CcSEcCtD
Dexmedetomidine—ADRA2C—midbrain—multiple sclerosis	0.000251	0.0242	CbGeAlD
Dexmedetomidine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00025	0.000785	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00025	0.000784	CcSEcCtD
Dexmedetomidine—Nausea—Prednisolone—multiple sclerosis	0.00025	0.000784	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000247	0.000775	CcSEcCtD
Dexmedetomidine—Vomiting—Triamcinolone—multiple sclerosis	0.000246	0.000772	CcSEcCtD
Dexmedetomidine—Vomiting—Methylprednisolone—multiple sclerosis	0.000245	0.00077	CcSEcCtD
Dexmedetomidine—ADRA2C—spinal cord—multiple sclerosis	0.000245	0.0236	CbGeAlD
Dexmedetomidine—Rash—Triamcinolone—multiple sclerosis	0.000244	0.000765	CcSEcCtD
Dexmedetomidine—Dermatitis—Triamcinolone—multiple sclerosis	0.000244	0.000765	CcSEcCtD
Dexmedetomidine—Rash—Methylprednisolone—multiple sclerosis	0.000243	0.000764	CcSEcCtD
Dexmedetomidine—CYP2D6—brainstem—multiple sclerosis	0.000243	0.0235	CbGeAlD
Dexmedetomidine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000243	0.000763	CcSEcCtD
Dexmedetomidine—Headache—Triamcinolone—multiple sclerosis	0.000242	0.000761	CcSEcCtD
Dexmedetomidine—Headache—Methylprednisolone—multiple sclerosis	0.000242	0.000759	CcSEcCtD
Dexmedetomidine—Abdominal pain—Prednisone—multiple sclerosis	0.000242	0.000758	CcSEcCtD
Dexmedetomidine—Body temperature increased—Prednisone—multiple sclerosis	0.000242	0.000758	CcSEcCtD
Dexmedetomidine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00024	0.000754	CcSEcCtD
Dexmedetomidine—Diarrhoea—Betamethasone—multiple sclerosis	0.00024	0.000754	CcSEcCtD
Dexmedetomidine—Hypotension—Methotrexate—multiple sclerosis	0.000239	0.000749	CcSEcCtD
Dexmedetomidine—SLC6A2—nervous system—multiple sclerosis	0.000233	0.0224	CbGeAlD
Dexmedetomidine—Dizziness—Dexamethasone—multiple sclerosis	0.000232	0.000728	CcSEcCtD
Dexmedetomidine—Dizziness—Betamethasone—multiple sclerosis	0.000232	0.000728	CcSEcCtD
Dexmedetomidine—Nausea—Triamcinolone—multiple sclerosis	0.00023	0.000721	CcSEcCtD
Dexmedetomidine—Nausea—Methylprednisolone—multiple sclerosis	0.000229	0.000719	CcSEcCtD
Dexmedetomidine—Dyspnoea—Methotrexate—multiple sclerosis	0.000228	0.000715	CcSEcCtD
Dexmedetomidine—Somnolence—Methotrexate—multiple sclerosis	0.000227	0.000713	CcSEcCtD
Dexmedetomidine—SLC6A2—central nervous system—multiple sclerosis	0.000224	0.0216	CbGeAlD
Dexmedetomidine—Vomiting—Betamethasone—multiple sclerosis	0.000223	0.0007	CcSEcCtD
Dexmedetomidine—Vomiting—Dexamethasone—multiple sclerosis	0.000223	0.0007	CcSEcCtD
Dexmedetomidine—Rash—Dexamethasone—multiple sclerosis	0.000221	0.000695	CcSEcCtD
Dexmedetomidine—Rash—Betamethasone—multiple sclerosis	0.000221	0.000695	CcSEcCtD
Dexmedetomidine—Dermatitis—Dexamethasone—multiple sclerosis	0.000221	0.000694	CcSEcCtD
Dexmedetomidine—Dermatitis—Betamethasone—multiple sclerosis	0.000221	0.000694	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00022	0.000692	CcSEcCtD
Dexmedetomidine—Headache—Betamethasone—multiple sclerosis	0.00022	0.00069	CcSEcCtD
Dexmedetomidine—Headache—Dexamethasone—multiple sclerosis	0.00022	0.00069	CcSEcCtD
Dexmedetomidine—ADRA2A—medulla oblongata—multiple sclerosis	0.000219	0.0211	CbGeAlD
Dexmedetomidine—Pain—Methotrexate—multiple sclerosis	0.000218	0.000686	CcSEcCtD
Dexmedetomidine—CYP2E1—medulla oblongata—multiple sclerosis	0.000214	0.0207	CbGeAlD
Dexmedetomidine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00021	0.000661	CcSEcCtD
Dexmedetomidine—Diarrhoea—Prednisone—multiple sclerosis	0.000209	0.000656	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000209	0.000656	CcSEcCtD
Dexmedetomidine—Nausea—Dexamethasone—multiple sclerosis	0.000208	0.000654	CcSEcCtD
Dexmedetomidine—Nausea—Betamethasone—multiple sclerosis	0.000208	0.000654	CcSEcCtD
Dexmedetomidine—ADRA2C—nervous system—multiple sclerosis	0.000206	0.0199	CbGeAlD
Dexmedetomidine—Dizziness—Prednisone—multiple sclerosis	0.000202	0.000634	CcSEcCtD
Dexmedetomidine—Abdominal pain—Methotrexate—multiple sclerosis	0.000202	0.000634	CcSEcCtD
Dexmedetomidine—Body temperature increased—Methotrexate—multiple sclerosis	0.000202	0.000634	CcSEcCtD
Dexmedetomidine—ADRA2A—midbrain—multiple sclerosis	0.0002	0.0193	CbGeAlD
Dexmedetomidine—ADRA2C—central nervous system—multiple sclerosis	0.000198	0.0191	CbGeAlD
Dexmedetomidine—ADRA2A—spinal cord—multiple sclerosis	0.000195	0.0188	CbGeAlD
Dexmedetomidine—Vomiting—Prednisone—multiple sclerosis	0.000194	0.00061	CcSEcCtD
Dexmedetomidine—ADRA2C—cerebellum—multiple sclerosis	0.000194	0.0187	CbGeAlD
Dexmedetomidine—Rash—Prednisone—multiple sclerosis	0.000193	0.000605	CcSEcCtD
Dexmedetomidine—Dermatitis—Prednisone—multiple sclerosis	0.000192	0.000604	CcSEcCtD
Dexmedetomidine—Headache—Prednisone—multiple sclerosis	0.000191	0.000601	CcSEcCtD
Dexmedetomidine—CYP2E1—spinal cord—multiple sclerosis	0.000191	0.0184	CbGeAlD
Dexmedetomidine—Nausea—Prednisone—multiple sclerosis	0.000181	0.00057	CcSEcCtD
Dexmedetomidine—SLC6A2—brain—multiple sclerosis	0.000178	0.0172	CbGeAlD
Dexmedetomidine—CYP1A1—nervous system—multiple sclerosis	0.000176	0.017	CbGeAlD
Dexmedetomidine—Diarrhoea—Methotrexate—multiple sclerosis	0.000175	0.000549	CcSEcCtD
Dexmedetomidine—CYP1A1—central nervous system—multiple sclerosis	0.00017	0.0164	CbGeAlD
Dexmedetomidine—Dizziness—Methotrexate—multiple sclerosis	0.000169	0.00053	CcSEcCtD
Dexmedetomidine—ADRA2A—nervous system—multiple sclerosis	0.000164	0.0159	CbGeAlD
Dexmedetomidine—Vomiting—Methotrexate—multiple sclerosis	0.000162	0.00051	CcSEcCtD
Dexmedetomidine—Rash—Methotrexate—multiple sclerosis	0.000161	0.000505	CcSEcCtD
Dexmedetomidine—CYP2E1—nervous system—multiple sclerosis	0.000161	0.0155	CbGeAlD
Dexmedetomidine—Dermatitis—Methotrexate—multiple sclerosis	0.000161	0.000505	CcSEcCtD
Dexmedetomidine—Headache—Methotrexate—multiple sclerosis	0.00016	0.000502	CcSEcCtD
Dexmedetomidine—ADRA2A—central nervous system—multiple sclerosis	0.000158	0.0153	CbGeAlD
Dexmedetomidine—ADRA2C—brain—multiple sclerosis	0.000158	0.0152	CbGeAlD
Dexmedetomidine—CYP2E1—central nervous system—multiple sclerosis	0.000155	0.0149	CbGeAlD
Dexmedetomidine—ADRA2A—cerebellum—multiple sclerosis	0.000155	0.0149	CbGeAlD
Dexmedetomidine—Nausea—Methotrexate—multiple sclerosis	0.000152	0.000476	CcSEcCtD
Dexmedetomidine—CYP2E1—cerebellum—multiple sclerosis	0.000151	0.0146	CbGeAlD
Dexmedetomidine—CYP1A1—brain—multiple sclerosis	0.000135	0.013	CbGeAlD
Dexmedetomidine—CYP2D6—nervous system—multiple sclerosis	0.000127	0.0123	CbGeAlD
Dexmedetomidine—ADRA2A—brain—multiple sclerosis	0.000126	0.0121	CbGeAlD
Dexmedetomidine—CYP2E1—brain—multiple sclerosis	0.000123	0.0119	CbGeAlD
Dexmedetomidine—CYP2D6—central nervous system—multiple sclerosis	0.000123	0.0118	CbGeAlD
Dexmedetomidine—CYP2D6—cerebellum—multiple sclerosis	0.00012	0.0116	CbGeAlD
Dexmedetomidine—CYP2D6—brain—multiple sclerosis	9.74e-05	0.00939	CbGeAlD
Dexmedetomidine—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	4.39e-05	0.00045	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	4.38e-05	0.000449	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—ALB—multiple sclerosis	4.31e-05	0.000442	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.3e-05	0.00044	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	4.3e-05	0.00044	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CCL5—multiple sclerosis	4.24e-05	0.000435	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.21e-05	0.000432	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	4.2e-05	0.000431	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	4.18e-05	0.000428	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL3—multiple sclerosis	4.17e-05	0.000428	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	4.13e-05	0.000423	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.13e-05	0.000423	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CCR5—multiple sclerosis	4.12e-05	0.000422	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	4.09e-05	0.00042	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL2RA—multiple sclerosis	4.06e-05	0.000416	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	4.04e-05	0.000414	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	4.03e-05	0.000413	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PTGER4—multiple sclerosis	4.02e-05	0.000412	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	4.01e-05	0.000411	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	4.01e-05	0.000411	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.01e-05	0.000411	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	4.01e-05	0.00041	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PGR—multiple sclerosis	3.96e-05	0.000406	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCR3—multiple sclerosis	3.88e-05	0.000398	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CCL5—multiple sclerosis	3.85e-05	0.000395	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CD28—multiple sclerosis	3.84e-05	0.000394	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—CCR5—multiple sclerosis	3.82e-05	0.000392	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.82e-05	0.000392	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.82e-05	0.000392	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	3.79e-05	0.000389	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCR2—multiple sclerosis	3.77e-05	0.000387	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—IL2RA—multiple sclerosis	3.77e-05	0.000386	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	3.77e-05	0.000386	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	3.76e-05	0.000386	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—IL2—multiple sclerosis	3.74e-05	0.000384	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.74e-05	0.000383	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	3.72e-05	0.000381	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—BCHE—multiple sclerosis	3.71e-05	0.00038	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	3.71e-05	0.00038	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	3.66e-05	0.000375	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	3.64e-05	0.000373	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	3.63e-05	0.000372	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	3.57e-05	0.000366	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—POMC—multiple sclerosis	3.54e-05	0.000363	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.52e-05	0.000361	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL3—multiple sclerosis	3.52e-05	0.000361	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	3.5e-05	0.000359	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—ALB—multiple sclerosis	3.5e-05	0.000359	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—IL2—multiple sclerosis	3.5e-05	0.000358	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.5e-05	0.000358	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CNR1—multiple sclerosis	3.48e-05	0.000357	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CCR5—multiple sclerosis	3.47e-05	0.000356	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	3.47e-05	0.000356	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	3.46e-05	0.000355	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	3.45e-05	0.000353	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL2RA—multiple sclerosis	3.42e-05	0.000351	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.42e-05	0.00035	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	3.42e-05	0.00035	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	3.41e-05	0.000349	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PTGER4—multiple sclerosis	3.39e-05	0.000347	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	3.37e-05	0.000345	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	3.34e-05	0.000342	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	3.33e-05	0.000342	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	3.28e-05	0.000337	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	3.27e-05	0.000335	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	3.24e-05	0.000332	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	3.22e-05	0.00033	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	3.22e-05	0.00033	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	3.2e-05	0.000328	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	3.19e-05	0.000327	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	3.18e-05	0.000326	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	3.15e-05	0.000323	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	3.15e-05	0.000322	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	3.14e-05	0.000321	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	3.13e-05	0.000321	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	3.13e-05	0.000321	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	3.11e-05	0.000318	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	3.06e-05	0.000314	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.03e-05	0.00031	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—BCHE—multiple sclerosis	3.01e-05	0.000309	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	2.99e-05	0.000306	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	2.94e-05	0.000301	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	2.94e-05	0.000301	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	2.92e-05	0.000299	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	2.91e-05	0.000298	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.9e-05	0.000297	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	2.89e-05	0.000296	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	2.86e-05	0.000293	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	2.86e-05	0.000293	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	2.86e-05	0.000293	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	2.84e-05	0.000291	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—IL2—multiple sclerosis	2.84e-05	0.000291	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	2.83e-05	0.00029	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	2.82e-05	0.000289	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	2.78e-05	0.000285	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.77e-05	0.000284	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.76e-05	0.000283	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	2.75e-05	0.000282	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	2.74e-05	0.000281	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	2.73e-05	0.000279	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	2.71e-05	0.000278	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	2.71e-05	0.000278	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	2.7e-05	0.000277	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	2.67e-05	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	2.67e-05	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	2.66e-05	0.000272	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	2.66e-05	0.000272	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	2.65e-05	0.000271	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	2.63e-05	0.00027	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	2.62e-05	0.000268	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	2.61e-05	0.000268	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—BCHE—multiple sclerosis	2.61e-05	0.000267	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	2.6e-05	0.000267	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	2.59e-05	0.000265	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	2.58e-05	0.000265	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	2.5e-05	0.000256	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	2.48e-05	0.000254	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	2.44e-05	0.00025	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	2.43e-05	0.000249	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	2.43e-05	0.000249	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	2.41e-05	0.000247	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	2.4e-05	0.000246	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	2.39e-05	0.000245	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	2.38e-05	0.000244	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	2.37e-05	0.000243	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	2.37e-05	0.000242	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	2.31e-05	0.000237	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	2.28e-05	0.000233	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	2.28e-05	0.000233	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	2.26e-05	0.000231	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.25e-05	0.00023	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	2.24e-05	0.00023	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—APOE—multiple sclerosis	2.23e-05	0.000229	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	2.22e-05	0.000227	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	2.21e-05	0.000227	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	2.21e-05	0.000226	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	2.2e-05	0.000226	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	2.2e-05	0.000225	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	2.17e-05	0.000223	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	2.17e-05	0.000223	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	2.16e-05	0.000222	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	2.16e-05	0.000221	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	2.15e-05	0.00022	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	2.15e-05	0.00022	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	2.11e-05	0.000216	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	2.08e-05	0.000213	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	2.05e-05	0.00021	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	2.02e-05	0.000207	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	2.02e-05	0.000207	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	2.01e-05	0.000206	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	2e-05	0.000205	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	2e-05	0.000205	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.99e-05	0.000204	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.97e-05	0.000202	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.96e-05	0.000201	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.96e-05	0.000201	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.93e-05	0.000198	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—POMC—multiple sclerosis	1.92e-05	0.000196	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	1.9e-05	0.000195	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.88e-05	0.000193	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.87e-05	0.000191	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	1.86e-05	0.000191	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.85e-05	0.00019	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.84e-05	0.000188	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.82e-05	0.000187	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.81e-05	0.000186	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.81e-05	0.000185	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.79e-05	0.000184	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.76e-05	0.00018	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ALB—multiple sclerosis	1.75e-05	0.000179	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.72e-05	0.000176	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.71e-05	0.000176	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	1.69e-05	0.000173	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.69e-05	0.000173	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.68e-05	0.000172	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.67e-05	0.000171	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.66e-05	0.000171	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.66e-05	0.00017	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.66e-05	0.00017	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.64e-05	0.000168	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.64e-05	0.000168	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.63e-05	0.000167	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.6e-05	0.000164	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.58e-05	0.000162	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOE—multiple sclerosis	1.57e-05	0.000161	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.57e-05	0.000161	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.56e-05	0.00016	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.54e-05	0.000158	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.53e-05	0.000157	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.52e-05	0.000156	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.52e-05	0.000155	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.51e-05	0.000155	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.43e-05	0.000147	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.42e-05	0.000146	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.42e-05	0.000146	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	1.41e-05	0.000144	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.4e-05	0.000144	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	1.4e-05	0.000143	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.37e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—POMC—multiple sclerosis	1.35e-05	0.000138	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	1.33e-05	0.000136	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.3e-05	0.000134	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.3e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	0.000131	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.27e-05	0.00013	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.26e-05	0.000129	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.25e-05	0.000128	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ALB—multiple sclerosis	1.23e-05	0.000126	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.2e-05	0.000123	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	1.19e-05	0.000121	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	1.18e-05	0.000121	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.18e-05	0.000121	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	1.18e-05	0.000121	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	1.17e-05	0.00012	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	1.16e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.16e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	1.12e-05	0.000115	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.1e-05	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.1e-05	0.000112	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-05	0.00011	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	1.07e-05	0.000109	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.01e-05	0.000104	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOE—multiple sclerosis	1e-05	0.000103	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	9.97e-06	0.000102	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	9.92e-06	0.000102	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	9.9e-06	0.000101	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	9.82e-06	0.000101	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	9.71e-06	9.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	9.63e-06	9.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	9.58e-06	9.82e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	9.27e-06	9.5e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ALB—multiple sclerosis	9.25e-06	9.48e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	9.25e-06	9.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	9.12e-06	9.35e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	9.11e-06	9.34e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	9.1e-06	9.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	9.07e-06	9.29e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	8.92e-06	9.14e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—POMC—multiple sclerosis	8.6e-06	8.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	8.26e-06	8.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	8.1e-06	8.3e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ALB—multiple sclerosis	7.84e-06	8.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	7.53e-06	7.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	7.51e-06	7.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	7.46e-06	7.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	7.36e-06	7.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	6.97e-06	7.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	6.86e-06	7.03e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	5.66e-06	5.8e-05	CbGpPWpGaD
